Latest filing published 12 Jul 2017 for Inhibitor Therapeutics, Inc..
Insider track record
No signal scores available.
HedgePath, LLC: trading record in brief
This profile gathers the share dealings of HedgePath, LLC in Inhibitor Therapeutics, Inc. Between 24 June 2014 and 30 June 2017, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 3 sales. The totals exclude 3 filings filed without an amount. Besides market trades, the filings include 2 share grants. So far in 2017, the count stands at no purchases and 1 sale.
The newest entry dates from 12 July 2017: an open-market sale, in Inhibitor Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 14 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to HedgePath, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500,000 sharesCommon Stock, $.0001 par value per shareSEC:0000899243-17-018211:0
- 2,560,000 sharesCommon Stock, $.0001 par value per shareSEC:0000899243-16-023280:0
- 82,156,842 sharesCommon Stock, $.0001 par value per shareSEC:0000899243-15-004745:1
- 20,000,000 sharesCommon Stock, $.0001 par value per shareSEC:0000899243-15-004745:0
- 20,000,000 shares@ US$0.075Common Stock, $.0001 par value per shareSEC:0001209191-14-046588:0
- 2,530,227 sharesCommon Stock, $.0001 par value per shareSEC:0001209191-14-046588:1
6 of 6 declarations